Product Images Tizanidine Hydrochloride

The text describes an improvement in the Ashworth Score using Tizanidine with a mean dose of 28.8 mg compared to a placebo. The data is presented for the end of titration, end of maintenance, and endpoint (last observation carried forward).*

This is a description of Tizanidine Hydrochloride Capsules. Each capsule contains 2.287 mg of tizanidine hydrochloride USP, which is equivalent to 2 mg tizanidine base. The usual dosage information is provided in the package insert. It should be stored at room temperature and out of reach of children. Zanaflex® is a registered trademark of Acorda Therapeutics Inc. These capsules are distributed by Aurobindo Pharma USA, Inc. and are made in India.*

This is a description of Tizanidine Hydrochloride Capsules manufactured by Ajanta Pharma. It contains 150 capsules that consist of 4mg Tizanidine base, indicated for muscle relaxation. Dosage details must be referred from the package insert. The capsules are to be stored at room temperature and in containers with a child-resistant closure. The drug must be kept out of children's reach. Distributed by Aurabindo Pharma in the USA, this drug is produced in India. There are also details about the code, manufacturing date, and the name of the registered trademark. The rest of the text is related to printing and packaging.*

This is a description of Tizanidine Hydrochloride Capsules, which come in a bottle of 150 capsules. Each capsule contains 6.862 mg of tizanidine hydrochloride USP, which is equivalent to 6 mg of tizanidine base. The usual dosage should be referred to the package insert for prescribing information. It is recommended to store at a temperature of 20° to 25°C (68° to 77°F) and keep it out of reach of children. The medicine is distributed by Aurobindo Pharma USA, Inc. in East Windsor, NJ, and manufactured in India. Zanaflex® is a registered trademark of Acorda Therapeutics Inc. There is some other information given but it is not useful for the description.*